November 20, 2026 · American family physician

Hyperlipidemia: Pharmacotherapy for Cardiovascular Risk Reduction in Adults.

Listen to this summary

This review addresses how clinicians should use risk calculators (PREVENT and Pooled Cohort Equations) and lipid-lowering medications to reduce cardiovascular risk in adults with and without established atherosclerotic cardiovascular disease. The authors conclude that statins remain first-line therapy for primary and secondary prevention, with nonstatin agents reserved for statin intolerance or inadequate LDL-C lowering, and that treatment decisions should be individualized through shared decision-making. The article also highlights special considerations for older adults, younger adults with elevated lifetime risk, and patients of childbearing potential.

Matthew B Nodelman, Morgan Adams Rhodes, Charles Carter

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play